Nowak, A K <br/><br/>
A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma.  [electronic resource] 

 -  British journal of cancer  Aug 2002 
 - 491-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6600505  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cisplatin--administration & dosage<br/>Deoxycytidine--administration & dosage<br/>Disease Progression<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Female<br/>Hematologic Diseases--chemically induced<br/>Humans<br/>Life Tables<br/>Male<br/>Mesothelioma--drug therapy<br/>Middle Aged<br/>Neoplasm Staging<br/>Pleural Neoplasms--drug therapy<br/>Quality of Life<br/>Respiratory Function Tests<br/>Survival Analysis<br/>Treatment Outcome<br/>Gemcitabine